James Hagedorn - Scotts Miracle Chairman of the Board, Chief Executive Officer
| SMG Stock | USD 67.96 0.26 0.38% |
Chairman
Mr. James Hagedorn is the Chairman of the Board, Chief Executive Officer of the Company. He has served as CEO of the Company since May 2001 and Chairman of the Board since January 2003. In addition to serving as CEO and Chairman of the Board, he served as President of the Company from October 2015 until February 2016, from November 2006 until October 2008 and from April 2000 until December 2005. Mr. Hagedorn is the brother of Katherine Hagedorn Littlefield, a director of the Company. since 2008.
| Age | 69 |
| Tenure | 16 years |
| Address | 14111 Scottslawn Road, Marysville, OH, United States, 43041 |
| Phone | 937 644 0011 |
| Web | https://scottsmiraclegro.com |
Latest Insider Transactions
Scotts Miracle Management Efficiency
The company has Return on Asset of 0.0398 % which means that on every $100 spent on assets, it made $0.0398 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4764) %, meaning that it generated no profit with money invested by stockholders. Scotts Miracle's management efficiency ratios could be used to measure how well Scotts Miracle manages its routine affairs as well as how well it operates its assets and liabilities. The Scotts Miracle's current Return On Equity is estimated to increase to 1.72, while Return On Tangible Assets are forecasted to increase to (0.12). At this time, Scotts Miracle's Intangible Assets are most likely to increase significantly in the upcoming years. The Scotts Miracle's current Other Assets is estimated to increase to about 764.5 M, while Non Current Assets Total are projected to decrease to roughly 1.3 B.Similar Executives
| Found 13 records | CHAIRMAN Age | ||
| Eric Wintemute | American Vanguard | 68 | |
| Yoav Doppelt | ICL Israel Chemicals | 52 | |
| Pierre Brondeau | FMC Corporation | 63 | |
| Stephen Furbacher | CF Industries Holdings | 72 | |
| Russell Girling | Nutrien | 58 | |
| Nir Gilad | ICL Israel Chemicals | 58 | |
| Robert Lumpkins | The Mosaic | 74 | |
| Stephen Hagge | CF Industries Holdings | 69 | |
| Gregory Ebel | The Mosaic | 56 | |
| Hugh Harvey | Intrepid Potash | 67 | |
| Johanan Locker | ICL Israel Chemicals | 61 | |
| Robert Jornayvaz | Intrepid Potash | 62 | |
| Jochen Tilk | Nutrien | 53 | |
Management Performance
| Return On Equity | -0.48 | ||||
| Return On Asset | 0.0398 |
Scotts Miracle Gro Leadership Team
Elected by the shareholders, the Scotts Miracle's board of directors comprises two types of representatives: Scotts Miracle inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scotts. The board's role is to monitor Scotts Miracle's management team and ensure that shareholders' interests are well served. Scotts Miracle's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scotts Miracle's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Hagedorn, Chairman of the Board, Chief Executive Officer | ||
| Brian Finn, Independent Director | ||
| Ivan Esq, Gen VP | ||
| Christopher Hagedorn, Division President | ||
| Craig Hargreaves, Director | ||
| Dave Swihart, Senior Development | ||
| Matthew Garth, Ex CFO | ||
| Nancy Mistretta, Independent Director | ||
| Thomas Coleman, Chief Financial Officer, Executive Vice President | ||
| Scott Hendrick, Senior Chain | ||
| Michael Lukemire, President, Chief Operating Officer | ||
| Cory Miller, Interim Chief Financial Officer, Senior Vice President | ||
| Dimiter Todorov, General EVP | ||
| Julie DeMuesy, Chief VP | ||
| Thomas Kelly, Independent Director | ||
| Michelle Johnson, Director | ||
| James McCann, Independent Director | ||
| John Vines, Lead Independent Director | ||
| Ivan Smith, Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary | ||
| Adam Hanft, Independent Director | ||
| Aimee DeLuca, Senior Relations | ||
| Stephen Johnson, Independent Director | ||
| Phil Jones, Senior Sales | ||
| Nathan Baxter, Executive COO | ||
| David Evans, Independent Director | ||
| Josh Peoples, VP Officer | ||
| Denise Stump, Executive Vice President - Global Human Resources, Chief Ethics Officer | ||
| Katherine Littlefield, Director | ||
| Gerald Volas, Independent Director | ||
| James King, Executive Vice President Chief Communications Officer | ||
| Peter Shumlin, Independent Director |
Scotts Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scotts Miracle a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.48 | ||||
| Return On Asset | 0.0398 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 7.16 B | ||||
| Shares Outstanding | 56.69 M | ||||
| Shares Owned By Insiders | 25.39 % | ||||
| Shares Owned By Institutions | 77.49 % | ||||
| Number Of Shares Shorted | 4.48 M | ||||
| Price To Earning | 6.67 X |
Currently Active Assets on Macroaxis
When determining whether Scotts Miracle Gro is a strong investment it is important to analyze Scotts Miracle's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Scotts Miracle's future performance. For an informed investment choice regarding Scotts Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scotts Miracle Gro. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Scotts Stock analysis
When running Scotts Miracle's price analysis, check to measure Scotts Miracle's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scotts Miracle is operating at the current time. Most of Scotts Miracle's value examination focuses on studying past and present price action to predict the probability of Scotts Miracle's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scotts Miracle's price. Additionally, you may evaluate how the addition of Scotts Miracle to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Scotts Miracle's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scotts Miracle. If investors know Scotts will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scotts Miracle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Dividend Share 2.64 | Earnings Share (7.04) | Revenue Per Share 61.014 | Quarterly Revenue Growth (0.22) |
The market value of Scotts Miracle Gro is measured differently than its book value, which is the value of Scotts that is recorded on the company's balance sheet. Investors also form their own opinion of Scotts Miracle's value that differs from its market value or its book value, called intrinsic value, which is Scotts Miracle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scotts Miracle's market value can be influenced by many factors that don't directly affect Scotts Miracle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scotts Miracle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scotts Miracle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scotts Miracle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.